Bio-Techne (TECH) EPS (Weighted Average and Diluted) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.16% |
| Dec 31, 2025 | -26.90% |
| Sep 30, 2025 | -21.98% |
| Jun 30, 2025 | -15.71% |
| Mar 31, 2025 | -31.38% |
| Dec 31, 2024 | -40.78% |
| Sep 30, 2024 | -10.71% |
| Jun 30, 2024 | -9.15% |
| Mar 31, 2024 | -23.06% |
| Dec 31, 2023 | -17.69% |
| Sep 30, 2023 | -7.18% |
| Jun 30, 2023 | -15.54% |
| Mar 31, 2023 | -3.73% |
| Dec 31, 2022 | -24.81% |
| Sep 30, 2022 | 5.54% |
| Jun 30, 2022 | -12.48% |
| Mar 31, 2022 | -8.91% |
| Dec 31, 2021 | 19.63% |
| Sep 30, 2021 | 27.58% |
| Jun 30, 2021 | -39.31% |
| Mar 31, 2021 | 6.70% |
| Dec 31, 2020 | 10.76% |
| Sep 30, 2020 | 6.35% |
| Jun 30, 2020 | 16.15% |
| Mar 31, 2020 | 7.20% |
| Dec 31, 2019 | 27.68% |
| Sep 30, 2019 | -10.38% |
| Jun 30, 2019 | -10.47% |
| Mar 31, 2019 | 6.23% |
| Dec 31, 2018 | -7.93% |
| Sep 30, 2018 | -9.47% |
| Jun 30, 2018 | 6.80% |
| Mar 31, 2018 | -10.39% |
| Dec 31, 2017 | 13.33% |
| Sep 30, 2017 | -9.71% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -7.26% |
| Dec 31, 2016 | -22.16% |
| Sep 30, 2016 | -7.54% |
| Jun 30, 2016 | -1.91% |
| Mar 31, 2016 | -0.72% |
| Dec 31, 2015 | -0.57% |
| Sep 30, 2015 | -2.99% |
| Jun 30, 2015 | 0.29% |
| Mar 31, 2015 | -5.66% |
| Dec 31, 2014 | 6.16% |
| Sep 30, 2014 | -2.33% |